Delivery Order SPE2DX22D0020-SPE2D826F13EG
- Not listed
- This delivery order, valued at $37,954.48, was awarded on January 12, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply deliveries to support federal medical procurement needs. The contract is structured as a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The funding agency is the Defense Logistics Agency's Medical Supply Chain, a defense-focused organization...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $11,293.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., on January 6, 2026. This firm fixed-price, competitively awarded delivery order is scheduled for completion by January 7, 2026, with performance at the contractor's facility in Conshohocken, Pennsylvania. The award represents a task order under AmerSourceBergen's larger Indefinite Delivery Contract with DLA...
- On January 8, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $34,643.25 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price delivery order, which has an ultimate completion date of January 9, 2026, was competitively awarded with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- On January 7, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,295.84 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of parent company Cencora, Inc. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 8, 2026, with performance taking place at the awardee's corporate office in Conshohocken, Pennsylvania. The delivery order represents a task order issued under a larger indefinite delivery...
- On January 6, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $12,276.00 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under AmerSourceBergen's parent company Cencora, Inc.'s larger indefinite delivery contract with DLA Troop Support Medical. The work will be performed at the...
- On January 9, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $1,396.80 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. This competitively awarded, firm fixed-price delivery order represents a child contract with no set-aside designation and is scheduled for completion by January 12, 2026. The award is issued under AmerSourceBergen's parent company Cencora, Inc.'s...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $1,450.60 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical products and medical supplies. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award authority. AmerSourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is one of the nation's largest pharmaceutical distributors...
- On January 12, 2026, the Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $138,741.12 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, which is not set-aside, is scheduled for completion by January 13, 2026, with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order executed under AmerSourceBergen's substantial...
- The U.S. Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $1,637.22 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 7, 2026, with an ultimate completion date of January 8, 2026. This firm fixed-price, non-set-aside delivery order represents a child contract under the parent entity Cencora, Inc. (doing business as AmerSourceBergen), and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery...
- On January 7, 2026, the Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $11,262.65 to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc. This firm fixed-price delivery order, with an ultimate completion date of January 8, 2026, represents a child award under a larger indefinite delivery contract vehicle. The contract was competitively awarded with no set-aside designation, and performance will occur at the awardee's Conshohocken,...
- SPE2DX22D0020Indefinite Delivery Contract
- SPE2DX22D0020-SPE2D826F13EGDelivery Order
This delivery order, valued at approximately $34,900, was awarded on January 11, 2026, to AmerSourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply delivery to support federal healthcare needs. The award represents a non-competitive, firm fixed-price delivery order under the Defense Logistics Agency (DLA) Medical Supply Chain program, with performance based in Conshohocken, Pennsylvania, and a completion deadline of January 12, 2026. No set-aside designation was applied to this award. AmerSourceBergen Drug Corp operates as a child entity under its parent company Cencora, Inc., and executes this delivery order under a substantially larger indefinite delivery contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026. This prime contract vehicle enables AmerSourceBergen to supply a comprehensive range of pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical supplies to support military healthcare programs globally. The company's federal contracting portfolio demonstrates extensive capability in fulfilling diverse pharmaceutical procurement requirements across multiple therapeutic domains for military treatment facilities and veteran healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $34.9k | 1/10/26 |